FI922434A - Produktion av rekombinant human interleukin-1-inhibitor. - Google Patents
Produktion av rekombinant human interleukin-1-inhibitor. Download PDFInfo
- Publication number
- FI922434A FI922434A FI922434A FI922434A FI922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A FI 922434 A FI922434 A FI 922434A
- Authority
- FI
- Finland
- Prior art keywords
- inhibitor
- rekombinant
- produktion
- human interleukin
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44265289A | 1989-11-29 | 1989-11-29 | |
US44265289 | 1989-11-29 | ||
US9006979 | 1990-11-29 | ||
PCT/US1990/006979 WO1991008285A1 (en) | 1989-11-29 | 1990-11-29 | Production of recombinant human interleukin-1 inhibitor |
Publications (3)
Publication Number | Publication Date |
---|---|
FI922434A0 FI922434A0 (fi) | 1992-05-27 |
FI922434A true FI922434A (fi) | 1992-05-27 |
FI104733B FI104733B (fi) | 2000-03-31 |
Family
ID=23757611
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI922434A FI104733B (fi) | 1989-11-29 | 1992-05-27 | Menetelmä ja plasmidi interleukiini 1:n inhibiittorin tuottamiseksi |
Country Status (17)
Country | Link |
---|---|
US (1) | US5453490A (fi) |
EP (1) | EP0502956B1 (fi) |
JP (1) | JP3014007B2 (fi) |
KR (1) | KR0182819B1 (fi) |
AT (1) | ATE152172T1 (fi) |
AU (1) | AU651955B2 (fi) |
BR (1) | BR9007883A (fi) |
CA (1) | CA2068320C (fi) |
DE (1) | DE69030582T2 (fi) |
DK (1) | DK0502956T3 (fi) |
ES (1) | ES2103305T3 (fi) |
FI (1) | FI104733B (fi) |
GR (1) | GR3024031T3 (fi) |
HK (1) | HK1006856A1 (fi) |
HU (1) | HUT64582A (fi) |
NO (1) | NO305290B1 (fi) |
WO (1) | WO1991008285A1 (fi) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075222A (en) | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
US6858409B1 (en) | 1988-05-27 | 2005-02-22 | Amgen Inc. | Nucleic acids encoding interleukin-1 inhibitors and processes for preparing interleukin-1 inhibitors |
US6159460A (en) * | 1988-05-27 | 2000-12-12 | Amgen Inc. | Method for treating interleukin-1 mediated diseases |
US6552170B1 (en) * | 1990-04-06 | 2003-04-22 | Amgen Inc. | PEGylation reagents and compounds formed therewith |
US5861476A (en) * | 1994-02-02 | 1999-01-19 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
US5786331A (en) * | 1994-02-02 | 1998-07-28 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
US5608035A (en) * | 1994-02-02 | 1997-03-04 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
US5880096A (en) * | 1994-02-02 | 1999-03-09 | Affymax Technologies N.V. | Peptides and compounds that bind to the IL-1 receptor |
IT1270662B (it) * | 1994-10-13 | 1997-05-07 | Applied Research Systems | Antagonista della interleuchina-1 |
US5837495A (en) * | 1994-10-13 | 1998-11-17 | Applied Research Systems Ars Holding N.V. | DNA encoding interleukin-1 antagonist |
US5981713A (en) * | 1994-10-13 | 1999-11-09 | Applied Research Systems Ars Holding N.V. | Antibodies to intereleukin-1 antagonists |
TW555765B (en) | 1996-07-09 | 2003-10-01 | Amgen Inc | Low molecular weight soluble tumor necrosis factor type-I and type-II proteins |
ATE406176T1 (de) * | 1996-12-06 | 2008-09-15 | Amgen Inc | Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
US6013253A (en) * | 1997-08-15 | 2000-01-11 | Amgen, Inc. | Treatment of multiple sclerosis using consensus interferon and IL-1 receptor antagonist |
US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
EP2087908B1 (en) | 2001-06-26 | 2018-05-30 | Amgen Inc. | Antibodies to opgl |
US20030191056A1 (en) | 2002-04-04 | 2003-10-09 | Kenneth Walker | Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins |
CA2497884C (en) | 2002-09-06 | 2013-10-22 | Brian Varnum | Therapeutic human anti-il-1r1 monoclonal antibody |
HUE040595T2 (hu) | 2004-04-02 | 2019-03-28 | Swedish Orphan Biovitrum Ab Publ | Eljárás IL-1ra aggregációjának csökkentésére |
PE20070684A1 (es) | 2005-11-14 | 2007-08-06 | Amgen Inc | MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP |
US20070248653A1 (en) * | 2006-04-20 | 2007-10-25 | Cochrum Kent C | Hemostatic compositions and methods for controlling bleeding |
US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
US10105441B2 (en) * | 2007-08-16 | 2018-10-23 | The Schepens Eye Research Institute, Inc. | Method for inhibiting or reducing dry eye disease by IL-1Ra |
WO2009062339A1 (en) | 2007-11-14 | 2009-05-22 | General Regeneratives, Ltd. | Methods of using interleukin-1 receptor antagonist as a myeloprotective agent |
EP2620139B1 (en) | 2008-02-27 | 2016-07-20 | Biomet Biologics, LLC | Interleukin-1 receptor antagonist rich solutions |
TW201117824A (en) | 2009-10-12 | 2011-06-01 | Amgen Inc | Use of IL-17 receptor a antigen binding proteins |
CN101690801B (zh) | 2009-10-26 | 2012-08-01 | 上海交通大学 | 白细胞介素-1受体拮抗剂的用途及其药物组合物 |
EP2598526B1 (en) | 2010-07-29 | 2018-09-05 | Eleven Biotherapeutics, Inc. | Chimeric il-1 receptor type i agonists and antagonists |
US20140234330A1 (en) | 2011-07-22 | 2014-08-21 | Amgen Inc. | Il-17 receptor a is required for il-17c biology |
WO2013019652A1 (en) * | 2011-07-29 | 2013-02-07 | Eleven Biotherapeutics, Inc. | Purified proteins |
CN104302772B (zh) | 2012-05-18 | 2017-11-10 | 爱德迪安(北京)生物技术有限公司 | 用于糖尿病治疗的蛋白、蛋白缀合物及其应用 |
DK2968468T3 (en) | 2013-03-13 | 2021-07-26 | Buzzard Pharmaceuticals AB | Chimeric cytokine formulations for ocular delivery |
US20140271589A1 (en) | 2013-03-15 | 2014-09-18 | Biomet Biologics, Llc | Treatment of collagen defects using protein solutions |
US9950035B2 (en) | 2013-03-15 | 2018-04-24 | Biomet Biologics, Llc | Methods and non-immunogenic compositions for treating inflammatory disorders |
US9895418B2 (en) | 2013-03-15 | 2018-02-20 | Biomet Biologics, Llc | Treatment of peripheral vascular disease using protein solutions |
US9758806B2 (en) | 2013-03-15 | 2017-09-12 | Biomet Biologics, Llc | Acellular compositions for treating inflammatory disorders |
US10143725B2 (en) | 2013-03-15 | 2018-12-04 | Biomet Biologics, Llc | Treatment of pain using protein solutions |
CA2929201A1 (en) | 2013-11-11 | 2015-05-14 | Ascendis Pharma Relaxin Division A/S | Relaxin prodrugs |
EP3074507B1 (en) | 2013-11-26 | 2022-01-05 | Biomet Biologics, LLC | Methods of mediating macrophage phenotypes |
WO2015191783A2 (en) | 2014-06-10 | 2015-12-17 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
US10041044B2 (en) | 2016-07-29 | 2018-08-07 | Trustees Of Boston University | Age-associated clonal hematopoiesis accelerates cardio-metabolic disease development |
US11285196B2 (en) | 2017-03-13 | 2022-03-29 | Eslam Abbas Baseuny | Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof |
WO2020035482A1 (en) | 2018-08-13 | 2020-02-20 | Iltoo Pharma | Combination of interleukin-2 with an interleukin 1 inhibitor, conjugates and therapeutic uses thereof |
WO2023222565A1 (en) | 2022-05-16 | 2023-11-23 | Institut National de la Santé et de la Recherche Médicale | Methods for assessing the exhaustion of hematopoietic stems cells induced by chronic inflammation |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3855747T2 (de) * | 1987-08-26 | 1997-06-12 | Biogen Inc | Biologische materialien, deren herstellung und verwendung in der therapie |
KR0148009B1 (ko) * | 1988-05-27 | 1998-08-01 | 그래고리 비. 아보트 | 인터루킨-1 억제제 |
US5075222A (en) * | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
WO1991017184A1 (en) * | 1990-04-27 | 1991-11-14 | The Upjohn Company | Modified interleukin-1 inhibitors |
DE69131044T2 (de) * | 1990-05-01 | 1999-11-18 | Chiron Corp., Emeryville | Interleukin-i antagonist und seine verwendung |
-
1990
- 1990-11-29 AU AU69007/91A patent/AU651955B2/en not_active Expired
- 1990-11-29 CA CA002068320A patent/CA2068320C/en not_active Expired - Lifetime
- 1990-11-29 WO PCT/US1990/006979 patent/WO1991008285A1/en active IP Right Grant
- 1990-11-29 DE DE69030582T patent/DE69030582T2/de not_active Expired - Lifetime
- 1990-11-29 ES ES91900515T patent/ES2103305T3/es not_active Expired - Lifetime
- 1990-11-29 HU HU9201777A patent/HUT64582A/hu unknown
- 1990-11-29 EP EP91900515A patent/EP0502956B1/en not_active Expired - Lifetime
- 1990-11-29 BR BR909007883A patent/BR9007883A/pt not_active Application Discontinuation
- 1990-11-29 AT AT91900515T patent/ATE152172T1/de not_active IP Right Cessation
- 1990-11-29 JP JP3501112A patent/JP3014007B2/ja not_active Expired - Lifetime
- 1990-11-29 DK DK91900515.7T patent/DK0502956T3/da active
-
1992
- 1992-05-27 FI FI922434A patent/FI104733B/fi active
- 1992-05-29 NO NO922138A patent/NO305290B1/no not_active IP Right Cessation
- 1992-05-29 KR KR1019920701272A patent/KR0182819B1/ko not_active IP Right Cessation
-
1994
- 1994-08-30 US US08/298,180 patent/US5453490A/en not_active Expired - Lifetime
-
1997
- 1997-07-09 GR GR970401686T patent/GR3024031T3/el unknown
-
1998
- 1998-06-22 HK HK98105919A patent/HK1006856A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE152172T1 (de) | 1997-05-15 |
CA2068320A1 (en) | 1991-05-30 |
HU9201777D0 (en) | 1992-12-28 |
HK1006856A1 (en) | 1999-03-19 |
CA2068320C (en) | 2000-10-17 |
EP0502956A1 (en) | 1992-09-16 |
DE69030582T2 (de) | 1998-06-25 |
EP0502956B1 (en) | 1997-04-23 |
AU651955B2 (en) | 1994-08-11 |
NO922138D0 (no) | 1992-05-29 |
EP0502956A4 (en) | 1992-12-09 |
GR3024031T3 (en) | 1997-10-31 |
FI104733B (fi) | 2000-03-31 |
NO305290B1 (no) | 1999-05-03 |
KR920703792A (ko) | 1992-12-18 |
HUT64582A (en) | 1994-01-28 |
JP3014007B2 (ja) | 2000-02-28 |
KR0182819B1 (en) | 1999-04-01 |
US5453490A (en) | 1995-09-26 |
JPH05503007A (ja) | 1993-05-27 |
FI922434A0 (fi) | 1992-05-27 |
WO1991008285A1 (en) | 1991-06-13 |
ES2103305T3 (es) | 1997-09-16 |
AU6900791A (en) | 1991-06-26 |
BR9007883A (pt) | 1992-09-29 |
NO922138L (no) | 1992-05-29 |
DE69030582D1 (de) | 1997-05-28 |
DK0502956T3 (da) | 1997-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI922434A (fi) | Produktion av rekombinant human interleukin-1-inhibitor. | |
IT1182721B (it) | Procedimento di purificazione di proteine ossee | |
DE68925724D1 (de) | Nichtkryogene niederdruckverarbeitung zur wiedergewinnung von äthylen | |
DE3769523D1 (de) | Schraubenkompressor. | |
HUT72187A (en) | Recombinant method and host for manufacture of xylitol | |
ATE38036T1 (de) | Benzothiophenderivate als bronchodilatoren. | |
IT8520350A0 (it) | Procedimento ed impianto per la pulitura di gas di scarto. | |
ITMI920794A0 (it) | Procedimento per la produzione di carbone attivo | |
IT8419730A0 (it) | Procedimento per la trasformazione quantitativa di teicoplanina a2fattore 1 in teicoplanina a2fattore 3. | |
EP0406211A3 (en) | Fucosidase inhibitors | |
IT8622548A0 (it) | Procedimento d'epurazione e di deodorizzazione di gas e installazione per la messa in opera di questo procedimento. | |
IT8721560A0 (it) | Procedimento per la purificazione di interferone. | |
ITMI922551A0 (it) | Procedimento per la produzione di carbone attivo | |
IT9020860A0 (it) | Procedimento per la depurazione fine di gas | |
DE3783092D1 (de) | Gaskompressor-steuerung. | |
IT1230866B (it) | Procedimento per la produzione di coke. | |
KR950702519A (ko) | 하이드로플루오로카본의 제조방법(production of hydrofluorocarbons) | |
IT8719420A0 (it) | Purificazione di interleuchina-1umana ricombinante. | |
IT1231506B (it) | Procedimento per la purificazione di polieteri polioli. | |
AU2885689A (en) | Novel proteins derived from human alpha2-plasmin inhibitor orproteins similar thereto | |
SE9300735L (sv) | Startblock | |
AU7422387A (en) | Tumor necrosis factor alpha as treatment for infectious diseases | |
IT1226147B (it) | Processo per la preparazione di perfluoro (2 bromoetilviniletere). | |
IT1233109B (it) | Servo-meccanismo per regolatori di pressione di gas | |
IT1247508B (it) | Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HC | Name/ company changed in application |
Owner name: AMGEN INC. |